Gray matter atrophy rate as a marker of disease progression in AD [PDF]
Global gray matter (GM) atrophy rates were quantified from magnetic resonance imaging (MRI) over 6- and 12-month intervals in 37 patients with Alzheimer's disease (AD) and 19 controls using: (1) nonlinear registration and integration of Jacobian values ...
Miller, David H. +29 more
core +1 more source
FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy [PDF]
Multiple system atrophy is a parkinsonian neurodegenerative disorder. It is cytopathologically characterized by accumulation of the protein p25α in cell bodies of oligodendrocytes followed by accumulation of aggregated α-synuclein in so-called glial ...
Christine L Kragh +52 more
core +2 more sources
The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. [PDF]
To assess the efficacy of 2% clindamycin vaginal cream (CVC) to treat bacterial vaginosis (BV) in ...
Sheehan, M +4 more
core +1 more source
Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
Vaginal laxity (VL) and genitourinary syndrome of menopause (GSM), as well as aesthetic changes in the vulvar skin, often occur together and cause physical, psychological, and functional problems for women and their partners.
Piotr Kolczewski +10 more
doaj +1 more source
A Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin (R)) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and Safety [PDF]
Aims: To investigate if vaginal application of dequalinium chloride (DQC, Fluomizin (R)) is as effective as vaginal clindamycin (CLM) in the treatment of bacterial vaginosis (BV).
Gerber, Stefan +14 more
core +1 more source
Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy
Vulvovaginal atrophy is frequent, can be bothersome and can impair quality of life in postmenopausal women. The main objective of this prospective, randomized study was to compare the acceptability of low-dose vaginal 17β-estradiol (estradiol) tablets ...
S. Palacios (810500) +2 more
core +1 more source
Vaginal atrophy in obstetrician-gynecologist practice [PDF]
Vaginal atrophy is a characteristic symptom of menopause, which can develop in young women as a result of temporary or permanent deficiency of estrogen, as well as after operations of the cervix or connective tissue diseases.
I G Shestakova
doaj
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
The ewe as an animal model of vaginal atrophy and vaginal Er:YAG laser application. [PDF]
peer reviewedOBJECTIVE: In sheep of reproductive age, we aimed to document decrease in epithelial thickness, glycogen amount, and other vaginal changes after castration and the effect of Er:YAG laser as used clinically.
Hympanova, Lucie +11 more
core +1 more source
Effect of Vitamin D on the Proliferation and Barrier of Atrophic Vaginal Epithelial Cells
Atrophic vaginitis is very common in postmenopausal women due to declining estrogen levels. Vitamin D plays an important role in promoting epithelial cell proliferation, migration and adhesion.
Dandan Li +5 more
doaj +1 more source

